home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  March 19, 2018
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 581 active entries

CBL Biopharma

PO Box 11069
Boulder, 80301
United States of America, Colorado

Phone: 303-317-3516
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


CBL Biopharma

CBL Biopharma is an independent, technology-based, privately owned biochemical company providing services to the chemical, pharmaceutical and biotech industry.CBL Biopharma is engaged in the innovation, development and supply of starting materials, intermediates and active ingredients for peptide pharmaceuticals.Today, CBL Biopharma is a company with one of the most modern state of the art large scale manufacturing of peptide products plant in the World. Our new high standard cGMP API-production facility has been on stream since June 2008. This new facility is located on our manufacturing site in Patras, Greece.

CBL Biopharma supports its clients with synthesis from the first lab trials up to full GMP production in tons quantities.

Large scale solid phase synthesis is the specialty of CBL Biopharma.
We have developed the scale up process and moreover built a highly automated plant dedicated to solid phase synthesis.
Batch sizes up to 500 kg in solid phase peptide synthesis are possible.

For more information please contact:

CBL Biopharma LLC
PO Box 11069
Boulder, Colorado

Tel.: 303-317-3516
Email: service@cblbiopharma.com

Selected Categories:
Product Company   Service Company
- General
- General
- General
- General
- Research
- Production

Last update of this entry: May 09, 2008

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.